| CTRI Number |
CTRI/2025/04/084605 [Registered on: 11/04/2025] Trial Registered Prospectively |
| Last Modified On: |
15/04/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Yoga & Naturopathy |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Acupuncture and Osteoarthritis of Knee |
|
Scientific Title of Study
|
To Determine the effect of selective Acupuncture points among the individuals with Osteoarthritis of knee -A Randomized Controlled Trial |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr V Ashtalakshmi |
| Designation |
PG Scholar |
| Affiliation |
International Institute of Yoga and Naturopathy Medical Sciences |
| Address |
184/4 International Institute of Yoga and Naturopathy Medical Sciences, Faculty block, Ground floor, Kamarajar nagar,Chengalpattu
Kancheepuram TAMIL NADU 603001 India |
| Phone |
9940026981 |
| Fax |
|
| Email |
drashtabnys@yahoo.co.in |
|
Details of Contact Person Scientific Query
|
| Name |
Dr N Prabu |
| Designation |
Assistant Medical Officer/ Lecturer Grade II |
| Affiliation |
International Institute of Yoga and Naturopathy Medical Sciences |
| Address |
184/4 International Institute of Yoga and Naturopathy Medical Sciences, Faculty block, Ground floor, Kamarajar nagar,Chengalpattu
Kancheepuram TAMIL NADU 603001 India |
| Phone |
9566351891 |
| Fax |
|
| Email |
drprabubnys91@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr N Prabu |
| Designation |
Assistant Medical Officer/ Lecturer Grade II |
| Affiliation |
International Institute of Yoga and Naturopathy Medical Sciences |
| Address |
184/4 International Institute of Yoga and Naturopathy Medical Sciences, Faculty block, Ground floor, Kamarajar nagar,Chengalpattu
Kancheepuram TAMIL NADU 603001 India |
| Phone |
9566351891 |
| Fax |
|
| Email |
drprabubnys91@gmail.com |
|
|
Source of Monetary or Material Support
|
| 184/4, International Institute of Yoga and Naturopathy Medical Sciences, Kamaraja Nagar, Chengalpattu 603001, Tamil Nadu, India |
|
|
Primary Sponsor
|
| Name |
Dr V Ashtalakshmi |
| Address |
184/4 International Institute of Yoga and Naturopathy Medical Sciences, Faculty block, ground floor, Kamarajar nagar, Chengalpattu |
| Type of Sponsor |
Other [self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr V Ashtalakshmi |
International Institute of Yoga and Naturopathy Medical Sciences, Chengalpattu |
184/4 International Institute of Yoga and Naturopathy Medical Sciences, Faculty block, ground floor, Kamarajar nagar, Chengalpattu Kancheepuram TAMIL NADU |
9940026981
drashtabnys@yahoo.co.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee, International Institute of Yoga and Naturopathy Medical Sciences, Chengalpattu-603001 |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: M179||Osteoarthritis of knee, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Acupuncture |
Patient undergoes needling on selective acupoints EX-LE-2, EX-LE-5, GB34, GV20, GB-31 for 20 minutes trice a week for 5 weeks |
| Comparator Agent |
Sham Acupuncture |
Patient will undergo sham acupuncture for 20 minutes trice a week for 5 weeks |
|
|
Inclusion Criteria
|
| Age From |
50.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
Both male and female patients of age group 50 to 65 years already diagnosed with osteoarthritis of knee for more than 6 months and willing to give consent for study are included. |
|
| ExclusionCriteria |
| Details |
people with other types of arthritis, congenital deformities, hairline fractures and fractures of knee. Patient with needle phobia and mentally unstable are excluded for the study |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Assessment of WOMAC (Western Ontario and Mcmaster universities Arthritis osteoarthritis index) scale |
Baseline and 5 weeks |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Assessment of Range of Motion of knee with Goniometer Scale |
Baseline and 5 weeks |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
23/04/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="1" Days="1" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identification.
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form Response - Clinical Study Report Response - Analytic Code
- Who will be able to view these files?
Response - Anyone
- For what types of analyses will this data be available?
Response - Any purpose.
- By what mechanism will data be made available?
Response (Others) - Online
- For how long will this data be available start date provided 05-06-2024 and end date provided 06-07-2025?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
Brief Summary
Modification(s)
|
Osteoarthritis is a chronic degenerative disorder of multifactorial aetiology characterized by the loss of articular cartilage, hypertrophy of bone at the margins, subchondral sclerosis, and range of biochemical changes and morphological alterations of the synovial membrane and joint capsule. Worldwide about 10–15% of all adults aged over 60 have some degree of osteoarthritis. While the global prevalence of knee & hip osteoarthritis was 3.8% and 0.85% respectively. India’s elderly population (>60 yrs) is set to increase drastically from around 7.4% in 2001 to around 19% in 2050. Several studies have suggested the potential benefits of acupuncture to generally improve symptoms such as joint pain, swelling and stiffness in osteoarthritis of knee. A Randomized controlled trial will be adopted for this study. The simple randomization method with 1:1 ratio will be done for 60 subjects get a sample size of (n=30) in each group. After obtaining informed consent, participants who fit the inclusion criteria will be randomly allocated into GROUP A (study group) GROUP B (control group). GROUP A will receive selective Acupuncture points at GB-31(FENGSHI), GB-34(YANGLINGQUAN), GV-20(BAIHUI), EX-LE-2(HEDING), EX-LE-5 (MEDIAL XIYAN & LATERAL XIYAN), to the affected knee for 20 minutes, three days per week and for 5 weeks. While the GROUP B (control group) will receive sham acupuncture for 20 minutes to the affected knee, thrice a week for 5 weeks. As a primary assessment WOMAC Scale is used to measure the difficulties in daily activities of the osteoarthritis patients at baseline and 5th week. As a Secondary outcome the range of motion of knees will be measured using the Goniometer on baseline and at 5th week. |